by Simone | April 17, 2024 1:21 pm
Does anyone know company what Oxford Club[1] is touting as ‘the inventor of the world’s first AI-designed drug to enter clinical trials’? The next Intuitive Surgical?
The company is tiny today – just $500 million – but it is in position to grow dramatically.
More info from ad:
And big pharma is lining up to use its patent-protected technology. Merck is collaborating with them on three projects that could generate up to $674 million in revenue. French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs. Bristol Meyers Squibb signed a $1.2 billion partnership with the company. You can see… each one of these projects is worth more than the entire market cap of this new AI stock!
Source URL: https://www.stockgumshoe.com/2024/04/microblog-who-is-oxford-club-touting-as-the-inventor-of-the-worlds-first-ai-designed-drug-to-enter-clinical-trials-the-next-intuitive-surgical/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
I believe they are referring to Exscientia
Yes, that’s EXAI — the ad from Alexander Green has been running since last year, I covered it here: https://www.stockgumshoe.com/reviews/oxford-club/answers-kansas-welder-story-leads-to-company-alex-green-believes-will-become-the-most-important-ai-company-in-the-world/
(several others have also teased EXAI over the past year or so, just FYI, most recently Ray Blanco)